Core Scientific (CORZ) Liabilities and Shareholders Equity (2020 - 2026)

Core Scientific (CORZ) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $3.1 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 104.9% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 billion (up 111.51% YoY) and the FY2025 annual result came in at $2.3 billion, up 59.06% from the prior year.
• Liabilities and Shareholders Equity rose to $3.1 billion in Q1 2026 per CORZ's latest filing, from $2.3 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $3.1 billion in Q1 2026, with the low at $664.2 million in Q2 2024.
• Average Liabilities and Shareholders Equity over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity surged 677.6% in 2022 and sank 71.89% in 2023.
• Core Scientific's Liabilities and Shareholders Equity stood at $807.7 million in 2022, then fell by 11.83% to $712.2 million in 2023, then surged by 107.25% to $1.5 billion in 2024, then jumped by 59.06% to $2.3 billion in 2025, then surged by 30.75% to $3.1 billion in 2026.
• Business Quant data shows CORZ's Liabilities and Shareholders Equity at $3.1 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.2 billion in Q3 2025.